Skip to Main Content

Paper Details

Cost Implications of Anticoagulation Strategies After Percutaneous Coronary Intervention Among Patients With Atrial Fibrillation (A PIONEER-AF PCI Analysis).
Am J Cardiol
2
2019
Atrial Fibrillation, DAPT, P2Y12, Patients, atrial fibrillation, cardiovascular events, patient, patients, rivaroxaban, vitamin K, warfarin
Author NameAffiliation
Roxana MehranThe Cardiovascular Institute, Mount Sinai Medical Center, Icahn School of Medicine at Mount Sinai
Eric D PetersonDuke Clinical Research Institute
Eric D PetersonDuke Clinical Research Institute
Keith A A FoxUniversity of Edinburgh and Royal Infirmary of Edinburgh
Duane S PintoBeth Israel Deaconess Medical Center, Harvard Medical School
  • 1 - 5

Datasets

Release 1.2